News and Events
Celebrating CCR Careers: Stefan Ambs, Ph.D., M.P.H.
Stefan Ambs, Ph.D., M.P.H., is a molecular epidemiologist whose expertise is in prostate and breast cancer with a focus on cancer health disparities and risk factors that alter the tumor microenvironment. After almost 25 years at the NCI, he retired in May 2025.
Read MoreClinical trial researching drug therapy for solid tumors
A clinical trial led by Hoyoung M. Maeng, M.D., Associate Research Physician in the Center for Immuno-Oncology, is researching a drug therapy for adults with advanced solid tumors.
Read MorePatient Testimonials
Read testimonials from patients and their families about their time at CCR.
Read MoreActivated gene elicits robust immune response in lung cancer
The activation of NOTCH1, a gene known to control cell differentiation and growth, stimulates a robust immune response in small cell lung cancer. Expression of this gene can also predict survival with immunotherapy.
Read MoreStudy uncovers new details on pulsing enzyme activity during cell cycle
Enzymatic activity during the start of the cell cycle could be harnessed to inhibit cancer cell reproduction.
Read MoreCancer Immunology Data Engine uncovers secreted proteins with therapeutic potential
CCR researchers have developed a new tool that identifies secreted proteins associated with immunotherapy outcomes.
Read MoreCCR-developed cancer therapy shrinks tumors and boosts immune response
A targeted cancer therapy developed at CCR shows promise in its ability to target a common cancer cell marker, both shrinking tumors and producing a boosted immune response.
Read MoreClinical trial researching drug therapy for colorectal cancer
A clinical trial led by Tim F. Greten, M.D., Deputy Chief and Senior Investigator in the Thoracic and GI Malignancies Branch, is researching a two-drug therapy for adults with metastatic colorectal cancer.
Read MoreSynthesized chemical component helps cancer drugs remain stable in water
Researchers developed a new chemical component that can be attached to drug molecules to make them more stable in water without losing effectiveness. This innovation could improve the performance of some cancer treatments.
Read MoreClinical trial researching immunotherapy for mesothelioma
A clinical trial led by Raffit Hassan, M.D., Chief and Senior Investigator in the Thoracic and GI Malignancies Branch, is researching an immunotherapy treatment for adults with solid tumors, including mesothelioma.
Read MoreClinical trial researching drug therapy for multiple myeloma
A clinical trial led by Elizabeth M. Hill, M.D., Assistant Research Physician in the Lymphoid Malignancies Branch, is researching a combination drug therapy for myeloid malignancies.
Read More